CHONDROGRID: A MULTICENTER RETROSPECTIVE CLINICAL TRIAL ON 70 PATIENTS

The intra-articular injection of CHondroGrid as a safe and effective treatment of symptomatic arthrosis of the knee. 

The sheet summarizes a retrospective multicenter study concerning the clinical data of 70 patients affected by knee arthrosis, treated with CHondroGrid (Bioteck). The medical records included the AP weight-bearing X-rays of the joint before treatment (baseline), and the Lequesne index, the WOMAC score, the subjective VAS score measured both at rest and in motion at the baseline, following each injection and 6 months after the third injection (follow-up). Following treatment with CHondroGrid, all the parameters covered by the study significantly decreased as of the very first injection; they further decreased following the second injection and then remained unchanged over time, unequivocally showing a long-lasting effect of the treatment with CHondroGrid on the symptoms of arthrosis. The study did not find any side effects associated with the use of the device. 

PRODUCTS USED: CHondroGrid CHG-004 CHG-PK4